TVM Capital Life Science has raised $201.6 million at the final closing of its latest venture fund drawing on a diverse group of investors from the Business Development Bank of Canada to Eli Lilly and Company. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals
